The 2021-2022 performance of cannabis stocks | Saxo Bank  The 2021-2022 performance of cannabis stocks | Saxo Bank  The 2021-2022 performance of cannabis stocks | Saxo Bank

The performance of cannabis stocks and the wider cannabis industry

Saxo Stories
Saxo Be Invested

Saxo Group

Summary:  How is the cannabis industry performing compared with other common equity themes? We explore the top traded cannabis stocks & the reason for their popularity.

Investing in the cannabis industry has been a source of debate among retail traders for some time. The legalisation of recreational and medicinal cannabis has been on the agenda for several countries in recent years, leading many to anticipate an investment surge in the pioneering cannabis stocks on the exchanges worldwide.

However, only Canada and Uruguay have formally legalised the commercial sale of cannabis for recreational use thus far. In the Netherlands, the drug remains illegal outright, but is legal for commercial sale in licensed cafes as well as personal use.

In the US, the policy towards cannabis has been developed on a state-by-state basis, with Joe Biden’s inauguration as President yet to commence federal legalisation nationwide. Nevertheless, medical cannabis is now legalised in over 50 nations globally, and it’s this trend which is helping to power the leading cannabis stocks from an investment perspective.

Below, we explore a host of cannabis stocks available to invest in as part of the Cannabis Equity Basket at Saxo Bank. It's worth noting that the Cannabis Equity basket is one of the lesser performing Equity Baskets at Saxo this year-to-date, being outranked by high performers like our Commodities and Defence Baskets. However, the development within the Cannabis Equity basket is still worth exploring.  

The performance of cannabis stocks globally in the past 5 years

It has been far from plain sailing for investors in the cannabis industry in recent years. Since the performance of cannabis stocks peaked at an average value of $142 in January 2018, it has been a downward trend ever since, falling to average lows of $17.25 in March 2020.

2019 was a particularly turbulent year for cannabis stocks. This was the year that cannabis investing was meant to evolve from pure speculation into legitimate long-term investments. Delays in licensing application approvals by Health Canada, the nation’s regulatory agency, inhibited recreational sales and stunted production of mainstream and derivative products. Meanwhile hefty taxation on US cannabis companies - coupled with the US being no closer to federal reforms of its cannabis legislation - and the hemorrhaging of money by many brand-name cannabis stocks, created continued uncertainty in the financial markets.

The most traded cannabis stocks globally in the past 3 months | Saxo Group

The biggest cannabis companies globally by market cap

As of March 2022, the three biggest players in the cannabis industry by market capitalization are Curaleaf (CURLF), Green Thumb Industries (GTII.CN) and Trulieve Cannabis (TRUL.CN). All three of which are American cannabis stocks.

Curaleaf is one of the leading medical and wellness cannabis producers and distributors in North America. With dispensaries now open in 23 US states, Curaleaf has grown to a market cap worth approximately $5.36 billion.

Meanwhile Chicago-based Green Thumb Industries and Florida-based Trulieve Cannabis have market caps valued at $4.44 billion and $4.67 billion, respectively.

The biggest cannabis companies globally by market cap | Saxo Group

The top traded cannabis stocks by Saxo customers

Looking at the investments in cannabis stocks made by Saxo customers of late, Tilray Brands Inc. (TLRY) stands out as the most traded cannabis company in the year to date, with almost a third (30.82%) of clients trading within this equity basket trading Tilray as of 25 March 2022.

In the last 12 months, Tilray Brands (29.05%) was second only to Sundial Growers Inc. (SNDL) (33.56%) as the most traded cannabis stock among Saxo customers.

Performance compared with Saxo’s other equity themes

If you’re an investor that’s increasingly focusing on equity themes as opposed to individual equities, it’s fair to say that cannabis stocks won’t have caught your eye in the last 12 months especially. The industry’s overall performance in the stock market is down 59.7% in the last year (as of 19-4-2022), making it Saxo’s poorest performing Equity Basket. It’s in the bottom ten of equity themes for the year-to-date too.

Delays and uncertainty surrounding the decriminalization and amendment to federal laws surrounding cannabis in the US have certainly played a key role here. Investors have grown increasingly jittery at the lack of recurring profitability among the leading cannabis stocks. There is no certainty that America’s legalization would push these companies firmly into the green either.


The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
Notification on Non-Independent Investment Research (
Full disclaimer (
Full disclaimer (

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15

Contact Saxo

Select region


Trade responsibly
All trading carries risk. Read more. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

This website can be accessed worldwide however the information on the website is related to Saxo Bank A/S and is not specific to any entity of Saxo Bank Group. All clients will directly engage with Saxo Bank A/S and all client agreements will be entered into with Saxo Bank A/S and thus governed by Danish Law.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.